Insider Trading

Notable insider buying and selling activity across public companies.

Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.

Articles

4,646 total articles

CME Group Director William R. Shepard Buys $437,101 of Stock

CME Group Director William R. Shepard Buys $437,101 of Stock

CME Group Director William R. Shepard purchased $437,101 worth of company stock on March 26, 2026, acquiring shares both directly and through a trust. The transactions occurred near the market price as the derivatives operator reports record open interest in U.S. Treasury products and moves to expand crypto trading hours.

Xilio Therapeutics Director Adds 5,000 Shares in March Transaction

Xilio Therapeutics Director Adds 5,000 Shares in March Transaction

Xilio Therapeutics director Shannon James Samuel purchased 5,000 shares of common stock on March 26, 2026, for a total of $43,949 at a reported price of $8.79 per share. The SEC filing notes transaction prices ranged from $8.6758 to $9.2499. After the purchase, Samuel directly owns 10,000 shares. The transaction occurs while XLO trades at $8.23 and…

Kopin CEO Executes Small Share Sale as Stock Trades Below Sale Price

Kopin CEO Executes Small Share Sale as Stock Trades Below Sale Price

Kopin Corporation CEO Michael Andrew Murray sold 5,413 shares on March 26, 2026, under a Rule 10b5-1 plan, netting $12,179. The transaction was disclosed in a Form 4 filing. Kopin's stock has fallen in recent trading and the company reported a fourth-quarter 2025 revenue miss tied to a government shutdown; Craig-Hallum retains a Buy rating and $6.0…

AAR Corp Legal Chief Executes Options, Sells Shares Worth $705K

AAR Corp Legal Chief Executes Options, Sells Shares Worth $705K

AAR CORP (NYSE: AIR) Senior Vice President, General Counsel, CAO, and Secretary Jessica A. Garascia exercised options to buy 6,284 shares and immediately sold the same number of shares on March 26, 2026. The sale generated $705,068 at $112.20 per share; the option exercises cost $346,064 at strike prices between $41.88 and $67.02. The transaction o…

Hercules Capital Director Elects Stock, Buys $104,998 in Shares; Analyst Notes and Loan Update Follow

Hercules Capital Director Elects Stock, Buys $104,998 in Shares; Analyst Notes and Loan Update Follow

DeAnne Aguirre, a director at Hercules Capital, purchased 7,317 shares of the business development company on March 26, 2026, electing stock in lieu of cash compensation. The transaction increased her direct and indirect holdings and coincides with Hercules releasing preliminary NAV estimates for year-end 2025, an amended loan commitment to Savara …

Hercules Capital Director Elects Stock, Buys $41,988 Worth of Shares

Hercules Capital Director Elects Stock, Buys $41,988 Worth of Shares

Hercules Capital director Paramjeet K Randhawa acquired 2,926 shares on March 26, 2026, through an election to receive equity in place of cash compensation. The purchase totaled $41,988 at an average price of $14.35 per share, executed in a price range of $14.31 to $14.39. The company stock is trading at $14.16, close to a 52-week low of $13.70. Th…

Hercules Capital Director Increases Stake with $105k Purchase as NAV Rises; Analyst Downgrade and Software Exposure Surface

Hercules Capital Director Increases Stake with $105k Purchase as NAV Rises; Analyst Downgrade and Software Exposure Surface

Hercules Capital director Nikos Theodosopoulos acquired 7,317 shares on March 26, 2026, spending $104,998 at an average price of $14.35. The purchase brings his direct holdings to 29,362 shares. The firm reported a modest increase in estimated NAV per share for year-end 2025 and faces investor scrutiny after a Piper Sandler downgrade and a short re…

Labcorp SVP and Chief Accounting Officer Sells $436,092 in Stock

Labcorp SVP and Chief Accounting Officer Sells $436,092 in Stock

Labcorp Holdings Inc. (NYSE: LH) SVP and Chief Accounting Officer Peter J. Wilkinson sold 1,633 shares on March 27, 2026, for $267.05 per share, generating $436,092. The sale was executed under a Rule 10b5-1 plan. The company recently reported fourth-quarter 2025 earnings that beat EPS expectations but missed revenue forecasts, and announced an exp…

Chemed CEO Sells $554K in Stock as Company Reports Soft Q4 Results

Chemed CEO Sells $554K in Stock as Company Reports Soft Q4 Results

Chemed Corp President and CEO Kevin J. McNamara sold 1,500 shares of company stock on March 27, 2026, for about $554,055. The transaction occurred as the stock traded near its 52-week low and after the company reported fourth-quarter 2025 results that missed analyst expectations, prompting an RBC Capital downgrade driven by concerns over Roto-Roote…

Japan Post trims Aflac stake with $1.6M sale of shares

Japan Post trims Aflac stake with $1.6M sale of shares

Japan Post Holdings Co., Ltd. sold 14,899 shares of Aflac Inc. on March 26, 2026, in two separate trades totaling $1.6 million. The sales came at prices between $107.04 and $108.29 per share. Aflac's most recent quarter showed a revenue beat and an EPS miss, and at current prices the stock is assessed as slightly overvalued by InvestingPro analysis…

AAR Corp CEO Disposes $9.5 Million in Shares After Option Exercises

AAR Corp CEO Disposes $9.5 Million in Shares After Option Exercises

AAR Corp (NYSE:AIR) Chairman, President and CEO John McClain Holmes III executed option exercises that produced 86,225 shares and then sold those shares for approximately $9.5 million across March 26 and 27. The exercised options were at prices between $37.66 and $37.74, and the sales transacted at prices ranging from $107.6039 to $112.4135. Follow…

Lemonade Director Increases Stake with $485k in Stock Purchases

Lemonade Director Increases Stake with $485k in Stock Purchases

Lemonade, Inc. director Maria Angelidis-Smith purchased a total of $485,478 in common stock on March 10, 2026, split between direct and trust transactions. The moves were disclosed in a Form 4/A filing with the Securities and Exchange Commission. The company recently reported fourth-quarter 2025 results that beat analyst expectations on both earnin…